A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of mi...
Saved in:
Main Authors: | Zhongjian Chen, Chenxi Yang, Zhenying Guo, Siyu Song, Yun Gao, Ding Wang, Weimin Mao, Junping Liu |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d667ec7deb8b4f9ebcd02aef60446ca3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
by: Giuseppe Mangiameli, et al.
Published: (2021) -
Diagnostic yield and safety of closed needle pleural biopsy in exudative pleural effusion
by: Govind Singh Rajawat, et al.
Published: (2017) -
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
by: Hiroto Yoneda, et al.
Published: (2021) -
Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
by: Joman Javadi, et al.
Published: (2021) -
MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
by: Wang Pei, et al.
Published: (2021)